RT @RichardPAConway: Nyam et al. JAK-pot study. >90000 treatment courses. No difference in aHR for treatment stop due
Tweet Content
Nyam et al. JAK-pot study. >90000 treatment courses. No difference in aHR for treatment stop due to adverse events in JAKi vs TNFi or non-TNF bDMARD. @RheumNow #EULAR2022 OP0266 https://t.co/3tgADvH1Bq https://t.co/2qLRzfMB9c
Links
EULAR Abstract Archive
http://scientific.sparx-ip.net/archiveeular/?c=a&searchfor=OP0266&view=1&item=2…
Show on Archive Page
On
Display in Search Results
On
PDQ
Off